Skip to content
Menu
Finabase Learn

Glossary

Immunization (bonds)

Funding a known payment on a known date by matching a bond holding's duration and present value to it, so a parallel rate move leaves it on target.

Immunization is a way to fund a known payment on a known date with bonds so that a change in interest rates does not leave the holding short. The rule, set out by the actuary Frank Redington in 1952, is to match the holding's Macaulay Duration to the time until the money is needed, and its value to the payment's present value. A parallel shift in yields then moves the bonds' price and the income from reinvested coupons in opposite directions by about the same amount.

Limits

  • The match decays. After four years the 10-year bond's duration is 5.26 against four years left, so the holding must be rebalanced.
  • Twists break it. A barbell of 3-year and 30-year bonds with the same duration ended $5,702 short when short yields fell to 4% and long yields rose to 6%.
  • Defaults and calls. It handles rate risk only. A callable bond changes its duration exactly when rates move.

A zero-coupon bond maturing on the date, such as a Treasury STRIP, pays one fixed sum with nothing to reinvest. That is called cash-flow matching. Pension funds and insurers immunize when suitable zeros are not available.

Sources and further reading

  1. F. M. Redington, “Review of the Principles of Life-Office Valuations,” Journal of the Institute of Actuaries, vol. 78 (1952)
  2. TreasuryDirect — STRIPS
  3. FINRA — Bonds: interest rate risk and reinvestment risk

Written and fact-checked by Finabase Research. Last reviewed . Spotted an error? Tell us.

Educational content, not investment advice. Finabase Learn explains how markets and tools work. It does not recommend any security or strategy, and examples are for illustration only. Investing involves risk, including the loss of principal. Rules and figures are for the United States unless stated and can change — check the cited source before you act. Data and corrections policy.